Regenexx Platelet Lysate – A Blood-Based Procedure Similar to Platelet-Rich Plasma, but with Preferred Characteristics for Many Orthopedic Uses.
“Lysate” comes from the Latin word lysis, which translates as “to break open.” So Platelet Lysate is made up of platelets that have been broken open in some way. Platelets contain alpha granules, which are small packets where their growth factors live. When you break open a platelet, the growth factors are released all at once rather than being released over a longer term. As a result, you can benefit from a higher dose of growth factors, in a shorter period of time, with a platelet lysate (PL) than if you used platelet-rich plasma (PRP). Similar to an immediate release pill, which releases a drug more quickly than a sustained release pill that releases a drug over a longer timeframe.
Platelet Lysate is made possible by utilizing a flexible Regenexx lab platform, which allows us to customize our regenerative orthopedic solutions to best meet the patient’s needs.
Video: Regenexx Super Concentrated Platelet Rich Plasma vs. Platelet Lysate
How We Use Platelet-Rich Plasma vs. Platelet Lysate?
PRP, or platelet-rich plasma, is a good solution for treating mild arthritis in joints, ligament tears, or small tendons. We’ve found that Platelet Lysate has preferred characteristics for use around nerves. For this reason, it is used extensively in the spine, where we encounter irritated nerves due to disc bulges. It’s also a useful option for treating nerve-related issues like carpal tunnel syndrome, or other similar types of conditions. To see how Regenexx-PL is used there, watch the video below, which shows a precision, ultrasound-guided, nerve hydrodissection.
Video: Precise Hydrodissection Using Ultrasound Guidance
Video: Treating Degenerative Disc Disease with Platelet Lysate or Other Regenexx Options.
Regenexx is a world leader in the field of orthopedic regenerative medicine based on scientific publications and is arguably the world’s most advanced platform for in-office interventional orthobiologics.
More than 156,950 highly specific image-guided Regenexx® Procedures have been performed since Regenexx pioneered the field of interventional orthopedics, using bone marrow concentrate to treat common orthopedic problems in 2005.
The published research on Regenexx procedures accounts for approximately 44% of the world’s research on the use of bone marrow concentrate for orthopedic conditions (cumulative n of patients published & treated with bone marrow concentrate as of 1/1/2019)
Regenexx Patient Outcome Data
Regenexx is unique in that it maintains an active patient registry that continually prompts patients to update their progress or side effects post-procedure. As a result, we keep records on tens of thousands of Regenexx procedures performed by physicians in our network in our outcomes database. Regenexx is the only company that has tracked an orthopedic patient population of this size, who were treated with bone marrow concentrate.
In our effort to be completely transparent with potential patients, we make these results available through our website. You can see for yourself how many procedures we’re tracking and the results patients have reported. With Regenexx, you have the tools you need to make an informed decision about what treatment option is right for you.
*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.